UY27293A1 - Uso de derivados selectivos de indirrubina como inhibidores de vegr-r - Google Patents

Uso de derivados selectivos de indirrubina como inhibidores de vegr-r

Info

Publication number
UY27293A1
UY27293A1 UY27293A UY27293A UY27293A1 UY 27293 A1 UY27293 A1 UY 27293A1 UY 27293 A UY27293 A UY 27293A UY 27293 A UY27293 A UY 27293A UY 27293 A1 UY27293 A1 UY 27293A1
Authority
UY
Uruguay
Prior art keywords
diseases
inhibitors
indirrubine
vegr
selective
Prior art date
Application number
UY27293A
Other languages
English (en)
Spanish (es)
Inventor
Rolf Jautelat
Olaf Prien
Gerhard Siemeister
Karl Heinz Thierauch
Gerhard Eisenbrand
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of UY27293A1 publication Critical patent/UY27293A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
UY27293A 2001-05-17 2002-05-16 Uso de derivados selectivos de indirrubina como inhibidores de vegr-r UY27293A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10125763A DE10125763A1 (de) 2001-05-17 2001-05-17 Verwendung selektiver Indirubinderivate als VEGF-R Inhibitoren

Publications (1)

Publication Number Publication Date
UY27293A1 true UY27293A1 (es) 2003-02-28

Family

ID=7686282

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27293A UY27293A1 (es) 2001-05-17 2002-05-16 Uso de derivados selectivos de indirrubina como inhibidores de vegr-r

Country Status (3)

Country Link
DE (1) DE10125763A1 (fr)
UY (1) UY27293A1 (fr)
WO (1) WO2002092079A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050154046A1 (en) * 2004-01-12 2005-07-14 Longgui Wang Methods of treating an inflammatory-related disease
US8563525B2 (en) 2004-01-12 2013-10-22 Natrogen Therapeutics International, Inc. Methods of treating an inflammatory-related disease
US7582670B2 (en) 2001-12-13 2009-09-01 Natrogen Therapeutics, Inc. Methods of treating an inflammatory-related disease
JP4037887B2 (ja) * 2003-01-15 2008-01-23 ロレアル ２−アルキリデンアミノオキシアセタミドを含むケア用またはメイクアップ用の組成物、毛髪またはまつ毛の成長を刺激し、および／またはそれらの喪失を遅らせるためのその使用
FR2849773B1 (fr) * 2003-01-15 2006-07-14 Oreal Composition capillaire contenant un 2-alkylidene aminooxy-acetamide, son utilisation pour stimuler la pousse des cheveux et/ou freiner leur chute
AR059066A1 (es) 2006-01-27 2008-03-12 Amgen Inc Combinaciones del inhibidor de la angiopoyetina -2 (ang2) y el inhibidor del factor de crecimiento endotelial vascular (vegf)
ATE547411T1 (de) 2006-12-04 2012-03-15 Jiangsu Simcere Pharmaceutical R & D Co Ltd 3-pyrrolo-cyclohexylen-2-dihydroindolinonderiva e und anwendungen davon
EP2621483A1 (fr) 2010-09-27 2013-08-07 Exelixis, Inc. Doubles inhibiteurs de met et vegf pour le traitement du cancer de la prostate résistant à la castration et des métastases osseuses ostéoblastiques
US9931400B2 (en) 2012-09-12 2018-04-03 Samsung Electronics Co., Ltd. Method of combination therapy for prevention or treatment of c-Met or angiogenesis factor induced diseases
CN103333161B (zh) * 2013-05-28 2015-09-30 滁州市洛达生物科技有限公司 1’-氧代靛玉红的制备和用途
CN107517589A (zh) 2015-01-08 2017-12-26 小利兰·斯坦福大学托管委员会 提供骨、骨髓及软骨的诱导的因子和细胞

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2194468T3 (es) * 1998-05-29 2003-11-16 Centre Nat Rech Scient Uso de derivados del bisindol indigoide para la fabricacion de un medicamento para inhibir quinasas dependientes de ciclinas.
US6664285B1 (en) * 1999-04-12 2003-12-16 Gerhard Eisenbrand Use of cell membrane penetrating indigoid bisindole derivatives
HUP0200724A3 (en) * 1999-04-12 2002-10-28 Eisenbrand Gerhard Indigoid bisindole derivatives and pharmaceurical compositions containing them
FR2801216A1 (fr) * 1999-11-23 2001-05-25 Centre Nat Rech Scient Utilisation de derives d'indirubine pour la fabrication de medicaments
DE10053474A1 (de) * 2000-10-24 2002-05-02 Schering Ag Schwefelhaltige Indirubinderivate, deren Herstellung und Verwendung
DE10061162A1 (de) * 2000-11-30 2002-07-11 Schering Ag Aryl-substituierte Indirubinderivate, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
WO2002092079A1 (fr) 2002-11-21
DE10125763A1 (de) 2002-11-28

Similar Documents

Publication Publication Date Title
UY27293A1 (es) Uso de derivados selectivos de indirrubina como inhibidores de vegr-r
DE69333109D1 (de) Therapeutische nukleoside
ATE254132T1 (de) Antivirale pyrimidin nucleoside derivate
WO2005021568A3 (fr) Nouveau nucleosides ou nucleotides tricycliques utillises comme agents therapeutiques
EA200100954A1 (ru) Производные камптотецина, обладающие противоопухолевой активностью
WO2003037860A3 (fr) Analogues de purine presentant une activite inhibitrice de hsp90
UY26886A1 (es) Polimorfos de un análogo de epotilona
ATE269321T1 (de) Arzneimittel gegen virale erkrankungen
DOP2000000109A (es) Derivados de tiazolilamida
UY26982A1 (es) Derivados de indirubina que contienen azufre, su preparación y uso
ES2102081T3 (es) Inductores de parainmunidad multipotentes basados en combinaciones de componentes de poxvirus, metodos para preparar los mismos, y su uso como farmacos.
EP2289515A3 (fr) Combinaison contenant une diaryl urée et un interferon
IT8819807A0 (it) Metodo per la costruzione di gallerie di grande luce mediante arco cellulare.
TR200402534T4 (tr) Viral enfeksiyonların tedavisinde yararlı oksazinokuinolonlar.
ATE287887T1 (de) Verbindungen, welche die freisetzung von cytokinen inhibieren
FI882385A0 (fi) Fosforhaltiga hmg-coa -reduktasinhibitorer, foerfarande foer framstaellning daerav och nya mellanprodukter.
DK315889A (da) Antivirale kombinationer, forbindelser der kan anvendes heri, og farmaceutiske praeparater med indhold af saadanne kombinationer.
FI932997A0 (fi) Antivirala foereningar
RU93055352A (ru) Способ получения 5-замещенных пирроло /2,3-d/ пиримидинов
SE0300034L (sv) Användning av stammar av Parapoxvirus ovis för framställning av antivirala läkemedel och läkemedel mot cancer
FI885811A (fi) Nya ammoniumfoereningar, deras framstaellning och anvaendning.
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
MX9305093A (es) Nuevos derivadosindano-2 mercaptoacetilamina triciclicos 2-sustituidos, utiles como inhibidores de la encefalinasa.
FI950229A (fi) Tetrasyklisiä yhdisteitä, menetelmä ja välituotteita niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina
IT8821877A0 (it) Componente di catalizzatore per laproduzione di poliolefine ad altissimo peso molecolare.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141216